Group One Trading, L.P. Zymeworks Inc. Transaction History

Group One Trading, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$4.65 - $7.43 $1,860 - $2,972	-400 Reduced 0.93%	42,552 $262,000
Q2 2022 Aug 11, 2022	SELL	$4.82 - $7.7 $182,051 - $290,829	-37,770 Reduced 46.79%	42,952 $228,000
Q1 2022 May 12, 2022	BUY	$6.0 - $16.98 $447,600 - $1.27 Million	74,600 Added 1218.56%	80,722 $529,000
Q4 2021 Feb 11, 2022	BUY	$15.19 - $29.33 $92,993 - $179,558	6,122 New	6,122 $100,000
Q3 2021 Nov 12, 2021	SELL	$27.35 - $37.28 $170,800 - $232,813	-6,245 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$26.5 - $38.23 $178,212 - $257,096	-6,725 Reduced 51.85%	6,245 $217,000
Q1 2021 May 12, 2021	BUY	$29.83 - $56.81 $100,437 - $191,279	3,367 Added 35.06%	12,970 $410,000
Q4 2020 Feb 10, 2021	BUY	$39.12 - $54.99 $375,669 - $528,068	9,603 New	9,603 $454,000
Q2 2020 Aug 13, 2020	SELL	$33.67 - $40.0 $116,026 - $137,840	-3,446 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$24.28 - $49.8 $83,668 - $171,610	3,446 New	3,446 $122,000
Q4 2019 Feb 10, 2020	SELL	$24.84 - $45.46 $104,054 - $190,431	-4,189 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$22.78 - $29.08 $86,290 - $110,155	3,788 Added 944.64%	4,189 $104,000
Q2 2019 Aug 09, 2019	BUY	$15.0 - $22.49 $6,015 - $9,018	401 New	401 $9,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $917M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.